FastMed Launches Online Weight Management Program with Authentic GLP-1 Medication

Audio By Carbonatix

HONG KONG SAR - Media OutReach Newswire - 19 December 2025 - Amid a global surge in demand for the weight-management ingredient GLP-1, the Hong Kong market has encountered challenges including illegal sales and online purchases made without a doctor’s prescription. In response, the local telemedicine and dispensing platform FastMed has introduced an authentic GLP-1 product, offering a safe and compliant online channel for individuals seeking support with weight management.
Weight Management Is a Serious Health Matter
Obesity is recognized by the World Health Organization as a chronic disease.1 Although GLP-1-based medications are highly sought after, FastMed emphasizes that these are prescription drugs. Inappropriate use may lead to serious side effects.
The platform has observed numerous informal channels selling weight-loss injections locally. Members of the public who use these without proper medical assessment may not only experience limited effectiveness but also face potential health risks. FastMed is committed to providing medical services, not merely “selling medications,” aiming to offer the public access to proper medical advice through regulated online channels and to reduce the circulation of non-compliant or counterfeit drugs.
Three-Step Safety Protocol: Consultation, Prescription & Delivery
Unlike conventional e-commerce platforms, FastMed’s weight management program follows a strict medical process:

1. Online Assessment: Users must complete a health questionnaire and undergo an online consultation. A doctor will evaluate suitability for GLP-1 medication based on BMI, medical history, and overall health.

1. Personalised Treatment Plan: A GLP-1 weight management plan is provided only if the doctor confirms it is medically appropriate.

1. Verification & Delivery: Following verification, the prescription is dispensed and delivered directly to the user, ensuring medication authenticity and traceability.
   

1. World Health Organization. (2024, March 1). Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

The issuer is solely responsible for the content of this announcement.

About 醫家有藥 FastMed

FastMed is an innovative telemedicine and online dispensing platform based in Hong Kong, providing convenient, efficient, and safe online consultation and medication delivery services.
For more information, visit: https://www.fastmedhk.com/